“showed a trend”

Three-back accuracy was significantly improved in individuals with EOS ( Z = −2.157, p = 0.031), whereas typically developing adolescents showed a trend of accuracy improvement ( Z = −1.949, p = 0.051) ( Table 1 ).

CTCAE toxicity grade before O 3 T was inversely correlated with time-lapse between the end of radiotherapy and rectal bleeding (rho = −0.588, p = 0.044) and showed a trend towards a borderline significant direct correlation with O 3 T duration (rho = 0.574, p = 0.051) and number of rectal O 3 T sessions (rho = 0.648, p = 0.059); that is, higher toxicity grade was related to earlier commencement of RB and longer treatment with O 3 T.

A comparison between the ECP groups showed a trend towards lower CK in the HTK group at six hours after replantation ( p = 0.051) but comparable CK levels at 12 h ( p = 0.095).

AQLQ scores showed a trend of improvement in Group 1 ( P = 0.051), and improvements in Group 3 ( P < 0.001) in patients treated with omalizumab at Week 24 ( Fig. 1 C).

1 l); the DI was significantly greater than 0 in Septin5 +/+ mice (one-sample t test, p = 0.022) and showed a trend in Septin5 −/− mice ( p = 0.051), and no significant genotype differences were observed in either the preference index or DI (Fig. 1 l).

In univariate analysis of the pilot patient results, only the presence of a BRAF mutation showed a trend toward significant correlation with increased CTC levels (p = 0.051).

The post hoc comparison showed a trend decrease (p = 0.051) in oxytocin level when participants in condition C3 were WR compared with when they were NWR (Fig. 3 ; see Supplementary Table S2 for all related statistics).

Univariate analysis for overall survival revealed that those patients at the S 2–3 stage and those receiving second-line therapies showed a trend of having an increased death risk (hazard ratio [HR] = 8.26, 95% confidence interval (CI), 0.99-68.67, p = 0.051; HR = 7.76, 95% CI, 0.93-64.99, p = 0.059, respectively).

On the other hand, JAG1 gene SNPs rs2235811 and rs2275811 showed a trend to association with FN-BMD and LS-BMD ( p = 0.051 and 0.089, respectively); well above the multiple test-significance threshold estimated at 0.009.

Lungworm infected harbour seals in AG 3 showed a trend towards reduced body weight (P = 0.051), whereas body length was unaffected.

In the pooled population with moderate and severe stroke, the ITT analysis showed a trend toward higher rates of any ICH and sICH in patients treated with tenecteplase (OR, 1.53 [95% CI, 0.99–2.66]; P =0.051 and OR, 2.51 [95% CI, 0.98–6.44]; P =0.054, respectively).

In one study by Ko et al., the proportion of solid volume showed a trend ( p = 0.051) in distinguishing invasive LPA compared to AIS and MIA combined.

We further observed that plasma levels of acetic acids correlated with IFN-γ (ρ = 0.301, p = 0.003) and showed a trend with TNF-α (ρ = 0.197, p = 0.051); plasma levels of butyric acids tended to correlate with IFN-γ (ρ = 0.194, p = 0.06) (eFigure 2).

Visual analysis Per-patient analysis showed a trend for a difference between Phases 1 and 2–3 in PET metabolism, which was more prominent in Phases 2–3 ( p = 0.051).

Among patients, continuous SE scores showed a trend toward a positive association with alpha diversity as measured by Inverse Simpson index ( p = 0.051).

Multivariate analysis showed that PIK3R1 expression status was an independent predictor of MFS in the total population (p = 0.0013), whereas PIK3CA mutation status only showed a trend in the ERBB2+ population (p = 0.051).

IL-6 and CRP were positively associated with high nuclease activity of isolates ( P < 0.001 and P = 0.049, respectively), while S100A8/9 showed a trend ( P = 0.051) indicating that in inflamed airways, S. aureus isolates with high nuclease are selected, thereby presumably facilitating escape from NETs ( 18 , 19 ).

Female patients showed a trend toward being 2.7 times more likely to be classified as C1 (OR = 2.67; 95% CI, 0.99–7.19; P = 0.051), although this result did not reach statistical significance.

Nonetheless, older age at surgery showed a trend toward being a protective factor ( p = 0.051; OR = 0.658), and higher preoperative ASA scores seem to be correlated to a major risk of SSI ( p = 0.08).

Hemoglobin drop was much less in the robotic group, thus confirming a significant superiority of robot-assisted LAR in this clinical setting, whereas overall use of blood products showed a trend in favor of the R-LAR patients (12 vs. 1 units of packed red blood cells, P = 0.051).

Among the time-domain measures, high HR max –HR min [odds ratio (OR), 0.579; 95% confidence interval (CI), 0.405–0.828; p = 0.003], SDNN (OR, 0.725; 95% CI, 0.578–0.909; p = 0.005), STD (OR, 0.044; 95% CI, 0.004–0.559; p = 0.016), and RMSSD (OR, 0.858; 95% CI, 0.755–0.975; p = 0.019) were associated with a low risk of PD, independent of age and sex, whereas pNN50 showed a trend of negative association with the risk of PD (OR, 0.784; 95% CI, 0.614–1.001; p = 0.051).

Luminal A tumors ( n = 93) had higher response rates than Luminal B tumors ( n = 43), (86.0% versus 69.8%; P = 0.047) and showed a trend toward higher CCCA rates (47.3% versus 27.9%; P = 0.051) ( Figure 1 C).

In the CAD cohort with a 2-year follow up, LDL-C levels measured within the last 3 months of follow up were significantly associated with an increased risk of BARC criteria 3 to 5 grade bleeding (P < 0.001) and showed a trend toward an increased risk of ICH (P = 0.051).

We compared US of the low capacity group between the pre- and post-training time points, and found that their post-training US showed a trend toward being reduced relative to their pre-training US ( t 13 = 2.15, p = 0.051).

The variant rs112076606 (A/G) showed a trend toward a significant association with both BMIC and UIC ( P = 0.051 and P = 0.081).